Cellectar Biosciences, Inc.

The momentum for this stock is not very good. Cellectar Biosciences, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Cellectar Biosciences, Inc..
Log in to see more information.
Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for th...

News